Sarepta: Enough, For God's Sake | Science | AAAS share.google/WcxLae5lKrqy...

Great conversation on vaccine hesitancy (and all things US vaccine policy) hosted by the folks at @busph.bsky.social yesterday. Here’s the recording www.youtube.com/watch?v=FSCw...

Health Economics Methods Advisory Group Releases Draft Report: Assessing Treatment Benefits in HTA Decision-Making tinyurl.com/yc47dejv

4.2 million people may lose coverage if Congress doesn't extend premium subsidies for ACA plans. “These are your friends, neighbors, and colleagues who [will] lose insurance, and their health [will] suffer as a result.”— @rachelwerner.bsky.social in @bloomberg.com. www.bloomberg.com/opinion/arti...

Was great fun to write this with Sarah Emond! A value-based approach could be used to reduce traditional access barriers and possibly mitigate back-end legislative remedies...

Val and I checked repeatedly because we simply couldn't believe no national or local news organizations covered this letter from 18 AGs in support of trans youth care and against FTC overreach. If you find any stories, let us know, but it seems to be our exclusive.

Institute for Clinical and Economic Review to Assess Vaccines for COVID-19: tinyurl.com/2tfn5pme

I was back at 26 Federal Plaza today, where an ICE agent violently threw this bereft woman to the ground in front of her kids. She had not touched him. She did not pose any threat. She had to be taken to the hospital. (🎥: Elias Eliahu)

A new paper led by Harvard Health Policy PhD student Ye Shen finds that, in the current policy environment, more than six in ten kids will have been enrolled in Medicaid for some period of time by their 18th birthday; the program is absolutley critical for children. jamanetwork.com/journals/jam...

Here’s what a Ball State University employee said that led to their termination:

Make your voice heard -- your opportunity to comment coming up! @htaiorg.bsky.social @cda-amc.bsky.social @nicecomms.bsky.social

The Health Economics Methods Advisory (HEMA) has a new website! hemamethods.org HEMA was convened by leaders at 3 global HTA organizations: ICER, @nicecomms.bsky.social, and @cda-amc.bsky.social to critically and independently examine and assess new methods and processes.

The first HEMA Draft Report will be published on September 24th, which will be open to public comment until October 15th. Mark your calendars and submit your public comments via [email protected]! Learn more: hemamethods.org

New @healthaffairs.bsky.social paper on how CMS can integrate formal aspects of #HTA, much of which is patterned after @icer-review.bsky.social practices! Many thanks to @commonwealthfund.org for their support. @basucally.bsky.social @leah-rand.bsky.social www.healthaffairs.org/doi/10.1377/...

@icer-review.bsky.social @tuftscevr.bsky.social @peterneumann11.bsky.social @pattysynnott.bsky.social

New @healthaffairs.bsky.social paper on how CMS can integrate formal aspects of #HTA, much of which is patterned after @icer-review.bsky.social practices! Many thanks to @commonwealthfund.org for their support. @basucally.bsky.social @leah-rand.bsky.social www.healthaffairs.org/doi/10.1377/...

#RIP to a kind, intelligent, and thoughtful researcher and evidence advocate. But as you can see from this @nytimes.com piece, also a true leader to the end: www.nytimes.com/2025/08/03/h...

Great application of our CEA Registry at the #Vanderbilt Center for Health Economic Modeling: 11 international fellows from #LMICs used the Registry to conduct CEAs of public health interventions. Read more at: tinyurl.com/88varaue @peterneumann11.bsky.social #ISPOR

Two weeks left to apply: Earn your #HEOR Certificate online from @tufts.edu with globally-recognized faculty like @peterneumann11.bsky.social, @dano-hta.bsky.social, James Chambers, and more from CEVR. Apply today! Deadline is Aug. 1. tinyurl.com/pr6drkhf #RWE #pharma

The Medsky feed is close to 200 likes, so if you can please support by liking, sharing, and pinning it! I know this sounds silly but the more engagement the feed receives the more likely it is that people will see there’s a dedicated space on Bluesky to discuss and share healthcare information.

Importantly, much work still to be done to explore the applicability of available frameworks and integration into #HTA processes. I look forward to the work ahead.

Traditional #valueassessment lacks methods to evaluate #oncology combination txs, posing challenges for drugmakers, HTA bodies, and payers. In a new commentary in Frontiers in Pharmacology, CEVR’s Dan Ollendorf et al explore available frameworks and chart a path forward: tinyurl.com/kh84ueb4

Pleased to introduce the 2025 cohort of the Tufts-CEVR CEA Registry Summer Fellowship Program, supported by the Gordon and Betty Moore Foundation. cevr.tuftsmedicalcenter.org/news/2025-ce... @tuftscevr.bsky.social @pattysynnott.bsky.social

Excited to contribute to a special issue of @BMJ_EBM, offering timely analysis on India’s experience of institutionalizing health technology assessment, with lessons for other LMICs. Read on to see an adaptation of a @icer-review.bsky.social HTA report for the Indian context! ⬇ bit.ly/4h2UGGC

This Friday -- at 12 PM ET join us for the virtual public meeting on the comparative clinical effectiveness and value of tolebrutinib (made by Sanofi) for the treatment of secondary progressive multiple sclerosis. Register here: shorturl.at/razPI #heor #hta

The FDA's AI, Elsa, can't even tell you who the FDA leadership is. Despite being updated thru April 2024, Elsa exclusively listed leaders who have left the FDA, including 3 that retired in 2022-23 and one that left in '21. More on Elsa (& which version of Claude it uses), only at AI Prognosis: 🖥️🩺

We're excited to announce Tufts-CEVR's new partnership with ISPOR to provide free, premium access to the CEA Registry for ISPOR members who are students or researchers in LMICs. More detail here: cevr.tuftsmedicalcenter.org/news/cevr-is... @djvanness.bsky.social @tuftscevr.bsky.social

CDC staff are still fighting the good fight with all available tools — including today’s MMWR email alert.

Looking forward to seeing colleagues and friends at ISPOR 2025 in lovely Montreal, QC next week! www.ispor.org/conferences-...

Excited to get this brand new book by Jerry Avorn from @portalresearch.org in the mail today! Can't wait to give it a read! @harvardmed.bsky.social

“There are only two genders!” “You can only study one of them!”

ICER will be attending #ISPORannual next month! To see the full list of ICER presenters, click here: icer.org/news-insight...

Thanks to all my wonderful Tufts-CEVR colleagues for putting on another great annual meeting! Proud to work with you! @dano-hta.bsky.social @brianreid.bsky.social @tuftscevr.bsky.social @mollytoba.bsky.social

Lawyers for Harvard University said the school will not comply with a new list of demands sent by the Trump administration on Friday.

The statute says "The Secretary shall approve" biological products that are "safe, pure, and potent." There's no room for disapproval based on the government having different "priorities." Industry should be screaming at the top of their lungs over this. www.law.cornell.edu/uscode/text/...

Please see below, you still have a chance to participate! Now open until April 25th.

@tuftscevr.bsky.social visiting PhD student Jan-Willem Versteeg has developed a survey on how ICER communicates uncertainty in its findings. Please share your opinion, using the link below or the QR code. Participation is completely anonymous! tinyurl.com/57hkmkum

@tuftscevr.bsky.social visiting PhD student Jan-Willem Versteeg has developed a survey on how ICER communicates uncertainty in its findings. Please share your opinion, using the link below or the QR code. Participation is completely anonymous! tinyurl.com/57hkmkum

Don't let this opportunity pass you by!

Felt strange closing up shop on my little non-profit that was supposed to help extend capacity in countries formalizing #HTA. I couldn’t do the 2 jobs I have and this, which was a disappointment; but in these times it feels like a crime. 😥💔 Long live #globalhealth

Really enjoyed chatting with Scott Howell, Mark Hansan, and Lou Garrison about defining value, connecting value and access, and making our health system work for all. Have a listen! open.spotify.com/show/659fsjT...

PhD student Jan-Willem Versteeg has fielded a survey to learn more about how @icer-review.bsky.social communicates uncertainty in its analyses. To learn more and participate visit this link: tinyurl.com/yc539c6v. Open for the next 3 weeks!

New research shows ".. that US commercial health plans cite HTA evidence, thus suggesting that they may consider HTA recommendations when formulating coverage". Great to have this documented, so that we can improve inescapable allocative decisions. www.jmcp.org/doi/10.18553... @dano-hta.bsky.social

Excited that HEMA is off and running! 🏃‍♂️🏎️🏍️

Health Economics Methods Advisory Group Selects First Area for Study: Assessing Treatment Benefits Appropriate to Consider in HTA Decision-Making icer.org/news-insight... #heor #hta

PhD student Jan-Willem Versteeg has fielded a survey to learn more about how @icer-review.bsky.social communicates uncertainty in its analyses. To learn more and participate visit this link: tinyurl.com/yc539c6v. Open for the next 3 weeks!

Institute for Clinical and Economic Review to Assess Treatment for Non-Cystic Fibrosis Bronchiectasis: tinyurl.com/mwd7rfrh

The #IRA #Medicare Part D benefit redesign may significantly lower OOP drug spending for beneficiaries with #dementia and multiple comorbidities. Read the new CEVR study in Value in Health for more details. authors.elsevier.com/a/1ke483vkP0...

ICER's Sarah and @dano-hta.bsky.social (Dan Ollendorf) collaborated with Utrecht University's Wim G. Goettsch to develop a paper discussing ways to improve evidence generation to meet health system needs. Read here: ascpt.onlinelibrary.wiley.com/doi/10.1002/...